By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Decision Resources Group 

260 Charles Street

Waltham  Massachusetts  02453  U.S.A.
Phone: 781-296-2500 Fax: 781-296-2550



Company News
Decision Resources Group To Host Biosimilars Seminar In London 3/26/2014 8:38:33 AM
Diane Corrado Joins Decision Resources Group As Executive Vice President, Sales And Marketing 3/11/2014 9:19:52 AM
Courtney Morris Joins Decision Resources Group as Executive Vice President, Solutions 9/10/2013 6:27:16 AM
Decision Resources Group Release: A Focus on Specialty Pharmacy at Las Vegas Pharmaceutical Conference 8/15/2012 9:55:47 AM
Decision Resources Group Release: Keynote Speakers Announced for Sixth Annual Pinsonault Managed Markets Summit 7/26/2012 10:06:53 AM
Decision Resources Group Release: Competition for Early-Line Biologic Use Among Psoriasis Patients Intensifies as Humira Continues to Gain Ground on Enbrel 10/5/2011 8:52:45 AM
Decision Resources Group Release: Over the Next Decade, the Malignant Melanoma Drug Market Will Increase More Than Seven-Fold to $1.5 Billion in 2020 10/4/2011 8:48:48 AM
Decision Resources Group Release: Biosimilar Versions of TNF-alpha Inhibitors and Pegylated IFN-alpha Agents Will Save Healthcare Systems $5.3 Billion in 2020 10/3/2011 9:56:31 AM
Decision Resources Group Acquires PharmaStrat 7/25/2011 10:46:53 AM
Decision Resources, Inc. Finds Despite FDA Label Revisions Regarding LABA-Containing Drugs, Patient Share of LABA/ICS Combination Drugs Exceed Patient Share of Single-Agent ICS Drugs in Recently Treated Asthma Patients 7/20/2011 6:55:19 AM